Jan 7 (Reuters) - Sanofi Aventis SA; Genzyme Corp discussing ways to assemble deal that would value Genzyme at about $80 per share -WSJ
((New York Equities Desk; tel: +1 646 223 6000))
(For more news about Sanofi Aventis SA click here:) COPYRIGHT Copyright Thomson Reuters 2011. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
((New York Equities Desk; tel: +1 646 223 6000))
(For more news about Sanofi Aventis SA click here:) COPYRIGHT Copyright Thomson Reuters 2011. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.